(Q34613884)

English

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

object named as

Lihong Yang

4

0 references

object named as

Meg J Jardine

6

0 references

object named as

Vlado Perkovic

3

0 references

object named as

Alan Cass

7

0 references

author name string

Wanyin Hou

1

1 reference

Europe PubMed Central

3 August 2017

Jicheng Lv

2

1 reference

Europe PubMed Central

3 August 2017

Na Zhao

5

1 reference

Europe PubMed Central

3 August 2017

Hong Zhang

8

1 reference

Europe PubMed Central

3 August 2017

Haiyan Wang

9

1 reference

Europe PubMed Central

3 August 2017

publication date

6 March 2013

1 reference

Europe PubMed Central

3 August 2017

European Heart Journal

1 reference

Europe PubMed Central

3 August 2017

34

1 reference

Europe PubMed Central

3 August 2017

24

1 reference

Europe PubMed Central

3 August 2017

1807-1817

1 reference

Europe PubMed Central

3 August 2017

Early recognition and prevention of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Pravastatin and cardiovascular risk in moderate chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Association between serum homocysteine and markers of impaired kidney function in adults in the United States

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT065

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHT065

1 reference

Europe PubMed Central

3 August 2017

release_x5d7gglsnnbbpnqzrr4mc2cuvm

1 reference

https://api.fatcat.wiki/v0/release/x5d7gglsnnbbpnqzrr4mc2cuvm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34613884&oldid=1965828747"